SPC444
Atogepant eða lyfjafræðilega viðunandi salt þar af
Status:
VeittApplication date:
1.11.2023Application published:
15.12.2023Grant published:
15.11.2025
Max expiry date:
9.11.2036Medicine name:
AquiptaMedicine for children:
No
Timeline
Today
1.11.2023Application
15.12.2023Publication
15.11.2025Registration
9.11.2036Expires
Marketing license
IS authorization number:
EU/1/23/1750Date:
30.8.2023
Foreign authorization number:
EU/1/23/1750Date:
11.8.2023
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2638042
Deadlines
TypeDeadline until
Type: Formgallafrestur, annar
Deadline until: 06.04.2024
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 10.10.2025